National and Kapodistrian University of Athens
Η επίδραση των αναστολέων του μετατρεπτικού ενζύμου της αγγειοτενσίνης στο ενδοθήλιο ασθενών με σακχαρώδη διαβήτη τύπου ΙΙ και διαβητική αμφιβληστροειδοπάθεια
Abstract
dc:descriptionEndothelial dysfunction has been described in patients with diabetes mellitus type II. Changes in th endothelium structures have been described in diabetic retinopathy. It has now been shown that the AC inhibitors slow the progress of diabetic retinopathy in normotensive type I patients. The benefit is greatest i those with relatively good metabolic control.This study was designed to study the effect of diabetes mellitu and ACE inhibitors on forearm blood flow (FBF) reactive hyperemia (RH) and to determine the relationshi between endothelial dysfunction and the type of retinopathy as v/ell as the effect of ACE inhibitors on th endothelium of patients with diabetic retinopathy.[METHOD: FBF was studied with venous occlusion plethysmography in 71diabetic patients.36 of them suffer© from diabetic retinopathy. The patients were divided into three groups. Group A included 25 patients who received quinapril, group B included 23 patients who received captopril and group C included 23 patients who received placebo. All patients underwent measurement of FBF at baseline and during RH. FBF during RH was measured every 15 sec for 3 min. Subsequently patients of group A received 20mg of quinapril orally, patients of group B received 25mg of captopril orally and patients of group C received placebo orally. FBF measurements at baseline and during RH were repeated 2 hours later.RESULTS: Administration of captopril or placebo did not alter FBF during baseline, the peak FBF during RH, the duration of RH or the vascular resistance during baseline or RH. Administration of quinapril did not alter the FBF during baseline and the vascular resistance during baseline or RH. Administration of quinapril increased the peak FBF during RH (p<0,05) and the duration of RH (p<0,05). Patients with background retinopathy (BR) had better FBF during RH (p=0,05) and longer RH (p<0,05) than patients with Retinitis - proliferans (RP). ACE Inhibitors administration improved the peak FBF during RH (p<0,05) and increased the duration of RH (p<0,05) in patients with RP but it had no effect in patients with BR.CONCLUSIONS: The administration of an ACE inhibitor with high relationship with tissue ACE (quinapril) improved the peak FBF during RH and the duration of RH in diabetic patients. This is possibly due to its antioxidant effect on endothelium and to the increased nitric oxide bioavailability Patients with BR had better endothelial function compared to patients with RP while ACE inhibitor administration improved the endothelial function in patients with RP. It is apparent that ACE inhibitor drugs may have an important role in limiting the progression of retinopathy in type II diabetes.The effect of ACE inhibitor therapy on retinopathy in type II diabetes requires urgent investigation.It is possible, in the future to seek the role of chronic administration of ACE inhibitors in the prevention and therapy of diabetic retinopathy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2004
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Rotsos, Trifon
- Ρότσος, Τρύφων
Subjects
dc:subject × 20- Ενδοθηλιακή λειτουργία
- Σακχαρώδης διαβήτης τύπου ΙΙ
- Αιματική ροή αντιβραχίου
- Αντιδραστική υπεραιμία
- Αναστολείς μετατρεπτικού ενζύμου
- Κιναπρίλη
- Παραγωγική αμφιβληστροειδοπάθεια
- Μη παραγωγική διαβητική αμφιβληστροειδοπάθεια
- Endothelial dysfunction
- Diabetes mellitus type II
- Forearm blood flow
- Reactive hyperemia
- ACE inhibitors
- Quinaprile
- Proliferative retinopathy
- Background retinopathy
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25552